AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

SELLAS Life Sciences Group, Inc. Director's Dealing 2016

Apr 29, 2016

33651_dirs_2016-04-28_da454fb0-48cd-495c-a3cf-5b3d93598ded.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Galena Biopharma, Inc. (GALE)
CIK: 0001390478
Period of Report: 2016-04-25

Reporting Person: GRAY MARY ANN (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock, par value $0.0001	39938	Direct